Related Experiment Video
Updated: Mar 3, 2026

10:02
High-frequency Ultrasound Imaging of Mouse Cervical Lymph Nodes
Published on: July 25, 2015
19.8K
How to use… lymph node biopsy in paediatrics
Sarah Farndon1,2, Sam Behjati1,3, Nico Jonas4
1Cancer Genome Project, Wellcome Trust Sanger Institute, Cambridge, UK.
Summary
Pediatric lymphadenopathy, or swollen lymph nodes in children, can cause concern for cancer. This interpretation discusses lymph node biopsy, the gold standard for diagnosing unknown causes, to guide clinical decisions.
Area of Science:
- Pediatric medicine
- Oncology
- Surgical pathology
Background:
- Lymphadenopathy is a frequent clinical observation in pediatric patients.
- Enlarged lymph nodes in children can cause significant parental and professional anxiety due to potential malignancy.
- Current high-quality evidence is limited for guiding referrals for lymph node biopsy in children.
Purpose of the Study:
- To interpret the current role and application of lymph node biopsy in the pediatric population.
- To provide guidance for healthcare professionals managing pediatric lymphadenopathy.
- To address the diagnostic challenges associated with enlarged lymph nodes in children.
Main Methods:
- Discussion of lymph node biopsy as a diagnostic tool.
- Review of the gold standard method for evaluating lymphadenopathy of unknown etiology.
- Interpretation of existing clinical practices and evidence.
Main Results:
- Lymph node biopsy, specifically excision biopsy, remains the gold standard for diagnosing pediatric lymphadenopathy of unknown cause.
- The interpretation highlights the need for clearer guidelines in referring children for biopsy.
- Discussion focuses on the clinical utility and interpretation of biopsy findings.
Conclusions:
- Lymph node biopsy is a critical diagnostic procedure for pediatric lymphadenopathy when the cause is uncertain.
- Further evidence is needed to refine referral criteria for lymph node biopsy in children.
- This interpretation aims to support informed clinical decision-making regarding pediatric lymphadenopathy evaluation.

